Spectranetics Corporation (SPNC) Selects Clinipace Inc. Worldwide to Manage Cardiovascular Device Clinical Study  
7/19/2011 7:17:57 AM

MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today that Spectranetics Corporation (Nasdaq: SPNC), a developer, manufacturer, marketer and distributer of single-use medical devices used in minimally invasive procedures within the cardiovascular system, has selected Clinipace to manage all aspects of a pivotal cardiovascular device clinical study that will serve as the basis for 510(k) notice submission.